Literature DB >> 9551956

IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy.

M Mochizuki1, J Bartels, A I Mallet, E Christophers, J M Schröder.   

Abstract

A common feature of some parasitic infections and allergic and atopic skin diseases is the involvement of Th2 lymphocytes and the dermal appearance of eosinophils (Eos). Because Th2 lymphocytes apparently do not release Eo attractants, we addressed the question of whether the Th2 cytokine IL-4 induces its production in dermal fibroblasts. We therefore stimulated fibroblasts with IL-4. HPLC investigation of supernatants revealed a single Eo chemotactic protein, which was purified to homogeneity giving a single 13-kDa band upon SDS-PAGE analyses. Peptide mapping with subsequent amino acid sequencing revealed an Eo-selective chemotaxin, which consists of a mixture of N-terminally truncated and O-glycosylated forms of the chemokine eotaxin. Other chemokines such as RANTES, MCP-3, MCP-4, or MIP-1alpha were not detected as Eo chemotaxins under these conditions. Using reverse transcriptase-PCR techniques, we found that IL-4 dose and time dependently induces eotaxin mRNA in dermal fibroblasts. Stimulation with IL-4 and TNF-alpha caused a 10- to 20-fold increase of the release of three biochemically different eotaxin forms, each consisting of a mixture of N-terminally truncated and O-glycosylated variants having the same backbone amino acid sequence but different specific activities. Our findings support the hypothesis that eosinophil recruitment seen in IL-4-mediated skin reactions, at least in part, may be due to Th2 cytokine-mediated induction of eotaxin in dermal fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551956

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

Review 1.  Chemokines and asthma: redundancy of function or a coordinated effort?

Authors:  N W Lukacs; S H Oliveira; C M Hogaboam
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 2.  Th1/Th2 balance in atopy.

Authors:  T Biedermann; M Röcken
Journal:  Springer Semin Immunopathol       Date:  1999

Review 3.  Eotaxin and asthma: some answers, more questions.

Authors:  C J Corrigan
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

4.  Isolation and purification of chemokines from natural sources.

Authors:  J M Schröder
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

Review 5.  Molecular machinations: chemokine signals in host-pathogen interactions.

Authors:  S W Chensue
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

6.  Osteopontin modulates inflammation, mucin production, and gene expression signatures after inhalation of asbestos in a murine model of fibrosis.

Authors:  Tara Sabo-Attwood; Maria E Ramos-Nino; Maria Eugenia-Ariza; Maximilian B Macpherson; Kelly J Butnor; Pamela C Vacek; Sean P McGee; Jessica C Clark; Chad Steele; Brooke T Mossman
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

7.  Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis.

Authors:  J M Spergel; E Mizoguchi; H Oettgen; A K Bhan; R S Geha
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 8.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

9.  Indomethacin inhibits eosinophil migration to prostaglandin D2 : therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis.

Authors:  Naoko Kataoka; Takahiro Satoh; Aiko Hirai; Kazumi Saeki; Hiroo Yokozeki
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

10.  Gene expression profiling in mouse liver infected with Clonorchis sinensis metacercariae.

Authors:  Dong Min Kim; Byung-Sam Ko; Jung-Won Ju; Shin-Hyeong Cho; Suk-Jin Yang; Young Il Yeom; Tong-Soo Kim; Yonggwan Won; Il-Chul Kim
Journal:  Parasitol Res       Date:  2009-11-10       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.